Skip to main content
. 2020 Aug 28;10:1501. doi: 10.3389/fonc.2020.01501

Table 1.

Correlation of SRD5A1 expression and clinical characteristics in CRC.

Characteristic n SRD5A1 expression (%) Pearson χ2 P
High Low
Total 100 58 (58) 42 (42)
Age 0.630 0.527
≥60 36 19 (52.78) 17 (47.22)
<60 64 39 (60.94) 25 (39.06)
Sex 0.725 0.412
Female 38 20 (52.63) 18 (47.37)
Male 62 38 (61.29) 24 (38.71)
Histological type 0.012 1.000
Ulcer type 72 42 (58.33) 30 (41.67)
Uplift type 28 16 (57.14) 12 (42.86)
Tumor site 0.001 1.000
Right colon 12 7 (58.33) 5 (41.67)
Left colon 88 51 (57.95) 37 (42.05)
Tumor size (cm) 0.029 1.000
≥5 49 28 (57.14) 21 (42.86)
<5 51 30 (58.82) 21 (41.18)
Pathological grade 9.044 0.004**
I–II 49 21 (9.71) 28 (90.29)
III–IV 51 37 (32.26) 14 (67.74)
Lymph node metastasis 9.873 0.002**
No 53 23 (43.40) 30 (56.60)
Yes 47 35 (74.47) 12 (25.53)
Distant metastasis 5.953 0.021*
No 85 45 (0.00) 40 (100.00)
Yes 15 13 (17.45) 2 (82.55)
Survival status 6.787 0.034*
Death 20 16 (80.00) 4 (20.00)
Tumor survival 6 5 (83.33) 1 (16.67)
Disease-free survival 70 36 (51.43) 34 (48.57)
*

P < 0.05,

**

P < 0.01,

***P < 0.001.